Glow-in-the-Dark dye could help surgeons spot hidden breast cancer
NCT ID NCT05900986
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new imaging dye called LS301-IT in 22 women with early-stage breast cancer (DCIS or stage I-II) who were having a partial mastectomy. The dye is injected into a vein before surgery to make cancer cells glow, helping surgeons see and remove them more accurately. The main goals were to check safety and how well the dye works to spot cancer during the operation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Integro Theranostics Clinical Research Site #8
Winston-Salem, North Carolina, 27103, United States
-
Integro Theranostics Research Site #10
Cleveland, Ohio, 44195, United States
-
Integro Theranostics Research Site #12
Washington D.C., District of Columbia, 20059, United States
-
Integro Theranostics Research Site #2
Scottsdale, Arizona, 85260, United States
-
Integro Theranostics Research Site #3
Dallas, Texas, 75290, United States
-
Integro Theranostics Research Site #5
Philadelphia, Pennsylvania, 19107, United States
-
Integro Theranostics Research Site #6
The Bronx, New York, 10461, United States
-
Integro Theranostics Research Site #9
Weston, Florida, 33331, United States
-
Integro Theronostics Research Site #1
Houston, Texas, 77030, United States